MOTS-c
Mitochondrial-derived peptide
What It Is
A small peptide encoded within mitochondrial DNA (rather than nuclear DNA), part of a relatively newer research category of "mitochondrial-derived peptides." Research interest here is largely academic/basic-science rather than product-driven.
Proposed Mechanism
Proposed to act as a regulator of metabolic homeostasis, with hypothesized roles in insulin sensitivity and exercise-related metabolic adaptation — based on early-stage animal and cell research; considered a hypothesis under investigation, not established human physiology.
Areas Researchers Are Investigating
- Metabolic regulation and insulin sensitivity (animal models)
- Exercise physiology and mitochondrial biology (basic science)
- Aging-related metabolic research (early-stage)
Human Evidence
Minimal. This compound is at a substantially earlier research stage than most others in this database — largely basic science and animal research, with very limited human data.
Animal / Preclinical Evidence
The primary evidence base — rodent metabolic studies and cell-culture research.
Current FDA / Regulatory Status
Not FDA-approved. Not in human clinical development at the scale of an approved-product pathway as of last review; treat any claims of clinical trials with particular skepticism and verify directly at clinicaltrials.gov.
Known Safety Information
No meaningful human safety data exists publicly. This should be stated plainly rather than speculated about.
Limitations of Evidence
Very early-stage basic science; discussion of this compound in consumer content should be framed clearly as "an area of early scientific interest," not as something with established effects in humans.